IL7R is activated by the ligand IL7, and over 10% of T-ALL cases have acquired mutations in IL7R, leading to continuous activation of Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling cascade (61). The gene discussed is IL7; the disease is acute lymphoblastic leukemia.